Could a routine mammogram hold more information than meets the eye? With the advent of artificial intelligence (AI), the potential to transform mammogram analysis into a tool for accurately predicting breast cancer risk is now a tangible reality. This game-changing development has emerged as a
The convergence of artificial intelligence and robotics promises significant advances in modern medicine, a topic recently underscored by the successful patient enrollment in the CANSCAN clinical trial. Spearheaded by Vexev, a prominent Australian medical device company, and U.S. Renal Care, this
Schizophrenia and severe mental illnesses present daunting challenges for the medical community, often leading to a fragmented understanding of their neurological underpinnings. This dilemma has inspired significant research efforts, one of the most revolutionary being the Living Brain Project
Antidepressant medications have been a cornerstone of mental health treatment for years, yet for some patients, they come with a significant drawback: unexpected side effects. Recent research led by the University of Tartu Institute of Genomics sheds light on this issue through an in-depth study of
The cancer treatment market is witnessing monumental shifts as leading innovations pave a new path, notably in the fight against mantle cell lymphoma (MCL). With Imbruvica (ibrutinib) being sanctioned by the European Commission as a frontline treatment, a significant transformation in cancer
In a strategic move that underscores the growing importance of advanced technologies in research, Hamilton Company recently announced the acquisition of UK Robotics and Trisonic Discovery. These companies are recognized innovators in laboratory automation, and this acquisition strengthens
In the realm of breast cancer research, Ivan Kairatov stands out as a biopharma expert bringing innovative insights to the understanding of tumor dynamics. Our conversation today centers around a groundbreaking study from Fox Chase Cancer Center, which deeply examines tumor growth rates and the
Understanding which hospitalized patients with cirrhosis face the highest risk of mortality is a pressing challenge in modern healthcare. Years of research and development have culminated in an AI model designed to accurately predict mortality risk for these patients, significantly aiding
In the realm of biopharmaceutical innovation, Ivan Kairatov stands as a distinguished figure, renowned for his expertise in research and development within the industry. Today, we delve into the groundbreaking approval by the European Commission of Darzalex for treating high-risk smouldering
Cryptosporidium is an intestinal parasite causing severe diarrhea and particularly affects children and those with weakened immune systems, posing significant public health challenges. Efforts to find fully effective treatments have historically faced setbacks due to the organism's adaptability and
